The New Stoners
People with well-established patterns of use (including frequent users) have probably learned to self-medicate the discomfort of withdrawal by using more cannabis.
Select Page
by C. Scott McMillin | May 19, 2022 | Addiction | 0 |
People with well-established patterns of use (including frequent users) have probably learned to self-medicate the discomfort of withdrawal by using more cannabis.
by C. Scott McMillin | May 16, 2022 | Addictive Substances | 0 |
by C. Scott McMillin | May 5, 2022 | Public Policy | 0 |
by C. Scott McMillin | May 2, 2022 | Addiction Clinicians | 0 |
by C. Scott McMillin | Mar 10, 2022 | Addictive Substances, Families | 0 |
by C. Scott McMillin | Mar 7, 2022 | Addictive Substances | 0 |
by C. Scott McMillin | Feb 17, 2022 | Public Policy | 0 |
The smaller, local, independent, licensed growers – intended to benefit from legalization– have instead found themselves all but shut out of the market, unable to compete with much cheaper offerings.
Read Moreby C. Scott McMillin | Jan 27, 2022 | Addiction Clinicians, Addictive Substances | 0 |
Bad intent is not required for an article or broadcast segment to qualify as potentially harmful misinformation. It only needs to be present in the most provocative way in the right forum.
Read Moreby C. Scott McMillin | Dec 16, 2021 | Addictive Substances | 0 |
The information isn’t getting out to the target population. Or even to the physicians and other practitioners responsible for their care.
Read Moreby C. Scott McMillin | Nov 25, 2021 | Addictive Substances | 0 |
The author cites a meta-analysis conducted by another group that some 47% of frequent cannabis users, both recreational and medical, were experiencing withdrawal symptoms.
Read Moreby C. Scott McMillin | Nov 15, 2021 | Addictive Substances | 0 |
As one observer put it, we know far more about vaping nicotine than we do about cannabis, and we don’t know that much about vaping nicotine.
Read Moreby C. Scott McMillin | Nov 11, 2021 | Public Policy | 0 |
We certainly can’t count on the emerging cannabis industry to supply us with all the necessary facts, any more than we could count on the drug reps from Purdue Pharma to educate our physicians about the true risks of long-term opioid use in the treatment of chronic pain.
Read Moreby C. Scott McMillin | Nov 8, 2021 | Addiction | 0 |
…the JAMA study is a testament to exactly how widespread pot use has been among youth, for a very long time now.
Read Moreby C. Scott McMillin | Oct 14, 2021 | In the News | 0 |
Something’s obviously going on with people’s central nervous systems and/or gastrointestinal tracts, but nobody seems to have a clear picture of what that might be.
Read Moreby C. Scott McMillin | Sep 13, 2021 | Programs | 0 |
Maybe those hours spent in activities where you couldn’t smoke did make a difference for some.
Read Moreby C. Scott McMillin | Aug 9, 2021 | Public Policy, Resources | 0 |
Incarceration can be costly, disruptive to families, and appears to do little to deter future drug use. And though people do change while incarcerated, it isn’t always for the better.
Read Moreby C. Scott McMillin | Jul 15, 2021 | Addictive Substances | 0 |
Nobody knows where to draw the line, however, between light and heavy use. That’s in part because the research is so far behind when it comes to cannabis.
Read Moreby C. Scott McMillin | Jul 1, 2021 | Addictive Substances | 0 |
Maybe less potent (we hope), but for now, it’s sitting there on the convenience store counter, in brightly colored packages with kid-friendly names.
Read More